CIK 0001579428
- Large accelerated filer
Axsome Therapeutics, Inc.
Sign in to watch- Ticker
- AXSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 454241907
- Phone
- +1 212-332-3241
- Business address
- ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,086,500
- in 1 filing, $2.1M under 10b5-1 plans
Net −$2,086,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-10 | Coleman Mark Director | Sale 10b5-1 | −643 | $249.00 | $160K | 30,389 |
| 2026-06-08 | Coleman Mark Director | Option exercise 10b5-1 | +1,429 | 31,032 | ||
| 2026-06-08 | Coleman Mark Director | Option exercise · Restricted Stock Units 10b5-1 | −1,429 | 0 | ||
| 2026-06-05 | Coleman Mark Director | Grant or award · Restricted Stock Units | +1,721 | 1,721 | ||
| 2026-06-02 | Coleman Mark Director | Sale 10b5-1 | −5,537 | $223.39 | $1.2M | 29,603 |
| 2026-06-01 | Coleman Mark Director | Sale 10b5-1 | −6,000 | $230.30 | $1.4M | 35,140 |
| 2026-05-29 | Coleman Mark Director | Sale 10b5-1 | −6,000 | $233.46 | $1.4M | 41,140 |
| 2026-02-26 | Coleman Mark Director | Sale 10b5-1 | −25,000 | $161.11 | $4.0M | 47,140 |
| 2026-02-23 | Coleman Mark Director | Option exercise | +6,250 | $4.95 | $31K | 72,140 |
| 2026-02-23 | Coleman Mark Director | Option exercise · Stock Option (Right to Buy) | −6,250 | 7,721 | ||
| 2026-02-20 | Coleman Mark Director | Option exercise | +12,485 | $4.95 | $62K | 65,890 |
| 2026-02-20 | Coleman Mark Director | Option exercise · Stock Option (Right to Buy) | −12,485 | 13,971 | ||
| 2026-02-10 | Coleman Mark Director | Option exercise | +5,193 | $8.02 | $42K | 53,405 |
| 2026-02-10 | Coleman Mark Director | Option exercise · Stock Option (Right to Buy) | −5,193 | 0 | ||
| 2025-09-08 | Coleman Mark Director | Purchase | +800 | $127.20 | $102K | 47,437 |
| 2025-09-08 | Coleman Mark Director | Purchase | +287 | $127.30 | $37K | 47,724 |
| 2025-09-08 | Coleman Mark Director | Purchase | +488 | $127.40 | $62K | 48,212 |
| 2025-06-06 | Coleman Mark Director | Grant or award · Stock Option (Right to Buy) | +3,166 | 3,166 | ||
| 2025-06-06 | Coleman Mark Director | Grant or award · Restricted Stock Units | +1,429 | 1,429 | ||
| 2025-05-28 | Coleman Mark Director | Sale 10b5-1 | −3,750 | $103.43 | $388K | 46,637 |
Page 1 of 4 · 69 trades